
|Articles|August 1, 2006
- Pharmaceutical Executive-08-01-2006
- Volume 0
- Issue 0
Getting Better
Is the golden age of drug development over? Fat chance. Decade-by-decade comparisons show how new medicines improve on old ones. And that's innovation.
Advertisement
Articles in this issue
about 20 years ago
Time Machineabout 20 years ago
States Curb Marketingabout 20 years ago
From the Editor: Take Your Seatabout 20 years ago
Viewpoint: In Your Wordsabout 20 years ago
Quiz Answersabout 20 years ago
Introduction: Pharm Exec at 25about 20 years ago
How Far We've ComeAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
5




